| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥0.165 | -72.5% | ||
| CN¥0.165 | -72.5% | ||
| CN¥0.60 | 216.96% | ||
| CN¥0.60 | 216.96% | ||
| CN¥0.1893 | |||
Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A pays a dividend yield (FWD) of 0.43%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €4.99
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A paid a dividend of CN¥0.17. For the next 12 months, Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A is expected to pay a dividend of CN¥0.17. This corresponds to a dividend yield of approximately 0.43%.
- The dividend yield of Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A is currently 0.43%.
- Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A pays annually dividends. Payout is in July.
- The next dividend for Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A is expected in July.
- Within the last 10 years, Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A has paid dividends in 3 of them.
- Dividends of CN¥0.17 are expected for the next 12 months. This corresponds to a dividend yield of 0.43%.
- Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A was on 12 May 2023 in the ratio 1:1.
- To receive the last dividend of Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A on 9 July 2024 in the amount of CN¥0.17 you had to have the stock in your portfolio before the ex-day on 9 July 2024.
- The last dividend was paid on 9 July 2024.
- In 2022, dividends of CN¥0.19 were paid by Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A.
- Dividends from Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Beijing Sun-Novo Pharmaceutical Research Co Ltd Class A is located in China.